1. | thisiswheremymon | |
2. | maclia | |
3. | asal3986 | |
4. | hoffman4568john | |
5. | hiphopmusic |
1. | thisiswheremymon | |
2. | maclia | |
3. | asal3986 | |
4. | hoffman4568john | |
5. | hiphopmusic |
1. | maclia 01/26/2018 Bigger than most are thinking |
2. | hoffman4568john 07/06/2018 Nomura Instinet sets PT at $420 |
3. | thisiswheremymon 01/25/2018 Biogen is acquiring KPT-350 and other assets targeting certain neurological conditions, including amyotrophi… |
4. | hoffman4568john 08/03/2018 Board authorizes program to repurchase up to $3.5B of the Company’s common stock |
5. | maclia 01/25/2018 Misses EPS estimates by $0.19. Beats on revenues. |
6. | hoffman4568john 07/24/2018 Beats EPS estimates by $0.71 and beats on revenues |
7. | maclia 04/22/2018 Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases |
8. | 56hdswg97z71 07/25/2018 Biogen & Eisai announce detailed results Of Phase II clinical study of BAN2401 |
9. | hiphopmusic 07/02/2018 Mizuho Securities sets PT at $423 |
10. | hiphopmusic 06/28/2018 Biogen Exercises Option to Increase Ownership in Samsung Bioepis |